VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
TWSTTwist Bioscience Corporation
$85.00$5.3B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksTWSTEarnings History

TWST logoTwist Bioscience Corporation (TWST) Earnings History

Net Loss

10 years of earnings data (2016–2025) · Currently unprofitable on a TTM basis

TTM Net Income
-$81M
● Net Loss
TTM EPS (Diluted)
$-1.32
Per share, diluted
YoY EPS Growth
+63.9%
Excellent
Net Margin
-20.6%
After-tax profitability
EPS Growth Rate (CAGR)
1YN/A
3YN/A
5YN/A
10YN/A
Operating Margin-36.2%
Gross Margin50.7%
Return on Equity-16.4%
Return on Assets-12.4%
Record Annual Net Income-$44MFY2016
Record Quarterly EPS$0.33Q3 2025
Consecutive Profitable Years0years
Q2 2026
Net Income-$44M
EPS (Diluted)$-0.71
YoY Growth+63.9%Excellent
QoQ Growth-44.3%Declining

Loading earnings history...

Twist Bioscience Corporation (TWST) Earnings Overview

As of June 24, 2026, Twist Bioscience Corporation (TWST) reported trailing twelve-month net income of -$81M, reflecting +63.9% year-over-year growth. The company earned $-1.32 per diluted share over the past four quarters, with a net profit margin of -20.6%.

Looking at the long-term picture, TWST's historical earnings data spans multiple years. The company achieved its highest annual net income of -$44M in fiscal 2016.

Twist Bioscience Corporation is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →

Compared to peers including ILMN ($853M net income, 19.6% margin), PACB (-$129M net income, -341.5% margin), BEAM (-$65M net income, -57.2% margin), TWST has room to improve margins relative to the peer group. Compare TWST vs ILMN →

TWST Earnings vs Peers

Earnings metrics vs comparable public companies

CompanyTTM Net IncomeTTM EPSNet MarginROEYoY GrowthCompare
TWST logoTWSTCurrent
-$81M$-1.32-20.6%-16.4%+63.9%—
ILMN logoILMN
$853M$5.5419.6%33.4%+170.9%
PACB logoPACB
-$129M$-0.42-341.5%-213.5%-70.1%
BEAM logoBEAM
-$65M$-0.63-57.2%-8.1%+82.3%
NTLA logoNTLA
-$395M$-3.33-609.9%-53.5%+27.4%
GH logoGH
-$433M$-3.30-42.4%-+6.7%
Best in group
Lowest in group

TWST Historical Earnings Data (2016–2025)

10 years
Fiscal Year Net Income YoY % Operating Income EPS (Diluted) Net Margin Op. Margin
2025-$78M+62.8%-$136M$-1.30-20.6%-36.2%
2024-$209M-2.0%-$221M$-3.60-66.7%-70.6%
2023-$205M+6.1%-$217M$-3.60-83.5%-88.6%
2022-$218M-43.2%-$235M$-4.04-107.0%-115.3%
2021-$152M-8.7%-$153M$-3.15-114.9%-115.4%
2020-$140M-30.0%-$140M$-3.57-155.3%-155.5%
2019-$108M-51.1%-$109M$-3.92-198.0%-200.1%
2018-$71M-20.1%-$71M$-2.68-280.2%-277.5%
2017-$59M-34.5%-$58M$-3.16-550.8%-543.2%
2016-$44M--$44M$-2.35-1943.1%-1924.0%

Download Data

Export TWST earnings history in CSV or JSON format

Free sign-in required to download data

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

TWST — Frequently Asked Questions

Quick answers to the most common questions about buying TWST stock.

What is TWST earnings per share (EPS)?

TWST trailing twelve-month (TTM) diluted EPS is $-1.32, reflecting +63.9% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2016 to 2025 is available in the table on this page.

What is Twist Bioscience Corporation's net income?

Twist Bioscience Corporation (TWST) trailing twelve-month net income is $-81M as of 2025. Earnings grew +63.9% year-over-year.

Is TWST profitable?

TWST is not currently profitable on a TTM basis, reporting a net loss of $-81M. Net margin is -20.6%. Investors should monitor for a return to profitability.

What is TWST's earnings growth rate?

TWST compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2016 to 2025.

What are TWST's profit margins?

Twist Bioscience Corporation net profit margin is -20.6%, operating margin is -36.2%, and gross margin is +50.7%. Below-average margins reflect competitive or cost pressures. Return on Equity is -16.4%.

Is TWST growing earnings?

Yes, TWST earnings are accelerating — EPS growth of +63.9% exceeds the 5-year CAGR of N/A. TTM net income reached $-81M. Earnings momentum is strengthening.

What was TWST's best earnings year?

Twist Bioscience Corporation's highest annual net income on record is $-44M, achieved in fiscal year 2016. Earnings history on this page spans 2016 to 2025 and includes all annual and quarterly figures.

What were TWST's earnings last quarter?

TWST's most recent reported quarter was Q2 2026. Net income was $-44M with diluted EPS of $-0.71. For a full breakdown of all quarters, see the quarterly earnings table on this page.

TWST Earnings Over Time (2016–2025)

Net income & EPS — annual and quarterly view